Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model.
Previous studies have shown that intrastriatal transplants of dopamine (DA)-rich fetal ventral mesencephalic (VM) tissue can correct denervation-induced changes in the cellular expression of neuropeptide and receptor mRNAs in the rat Parkinson model. However, with the standard transplantation approach normalization of all cellular parameters has not been obtained. This may be due either to the incomplete striatal reinnervation achieved by these transplants, or to the ectopic placement of the grafts. In the present study we have used a microtransplantation approach to obtain a more complete reinnervation of the denervated striatum (20 micrograft deposits spread over the entire structure). Neurons were also implanted directly into the substantia nigra. In rats with multiple intrastriatal VM transplants the lesion-induced upregulation of mRNAs encoding for preproenkephalin (PPE), the D(2)-type DA-receptor, and the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD(67)) was normalized throughout the striatum, whereas the lesion-induced downregulation of preprotachykinin mRNA was unaffected. Intranigral grafts of either fetal DA-rich VM tissue or GABA-rich striatal tissue did not induce any changes in striatal neuropeptide and D(2)-receptor mRNA expression despite significant behavioral improvement. Comparison of the behavioral data with levels of neuropeptide expression showed that in rats with intrastriatal VM transplants a complete normalization of striatal PPE and GAD(67) mRNA expression did not translate into a complete recovery of spontaneous motor behaviors. The results show that extensive DA reinnervation of the host striatum by multiple VM microtransplants is insufficient to obtain full recovery of all lesion-induced changes at both the cellular and the behavioral level. A full reconstruction of the nigrostriatal pathway or, alternatively, modulation of basal ganglia function by grafting in non-striatal regions may be required to further improve the functional outcome in the DA-denervated brain.
Winkler
C
C
Lund University, Wallenberg Neuroscience Center, Department of Physiological Sciences, BMC A11, S-22184. winkler.christian@mh-hannover.deLund, Sweden
Bentlage
C
C
Cenci
M A
MA
Nikkhah
G
G
Björklund
A
A
D018663:Adrenergic Agents / Q000633:toxicity; D000818:Animals; D001345:Autoradiography / Q000379:methods; D001479:Basal Ganglia / Q000378:metabolism*; D001931:Brain Mapping; D004195:Disease Models, Animal; D004622:Embryo, Mammalian; D004745:Enkephalins / Q000235:genetics / Q000378:metabolism; D020392:Entopeduncular Nucleus / Q000378:metabolism; D005260:Female; D016332:Fetal Tissue Transplantation; D005786:Gene Expression Regulation; D005968:Glutamate Decarboxylase / Q000235:genetics / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization / Q000379:methods; D009479:Neuropeptides / Q000235:genetics* / Q000378:metabolism; D016627:Oxidopamine / Q000633:toxicity; D020734:Parkinsonian Disorders / Q000378:metabolism; D011498:Protein Precursors / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000235:genetics / Q000378:metabolism; D012044:Regression Analysis; D012686:Septal Nuclei / Q000196:embryology / Q000637:transplantation*; D013378:Substantia Nigra / Q000196:embryology / Q000637:transplantation*; D015320:Tachykinins / Q000235:genetics / Q000378:metabolism
D018663:Adrenergic Agents; D004745:Enkephalins; D009479:Neuropeptides; D011498:Protein Precursors; D012333:RNA, Messenger; D017448:Receptors, Dopamine D2; D015320:Tachykinins; C044206:preprotachykinin; D016627:Oxidopamine; C033660:preproenkephalin; D005968:Glutamate Decarboxylase